Megan Null

5PUBLICATIONS
29CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsMajor global burdens of diseaseSub-acute careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 29, 2026
Human neonatal MR1T cells have more diverse TCR repertoires but reduced bacterial recognition than adult MR1T cells.

|Apr 16, 2025
Human Neonatal MR1T Cells Have Diverse TCR Usage, are Less Cytotoxic and are Unable to Respond to Many Common Childhood Pathogens.

Deborah A Lewinsohn, Dylan Kain, Wael Awad

|Apr 09, 2025
A narrative review of the pathophysiology of sepsis in sub-Saharan Africa: Exploring the potential for corticosteroid therapy.

Phoebe Gruccio, William S Girard, Amelia D Badipour

|Oct 22, 2024
The Universal Vital Assessment (UVA) score at 6 hours post-resuscitation predicts mortality in hospitalized adults with severe sepsis in Mbarara, Uganda.

Megan Null, Mark Conaway, Riley Hazard

|Feb 24, 2024
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.

Corinna A Kulicke, Gwendolyn M Swarbrick, Nicole A Ladd

Pageof 1

Frequent Collaborators

3 joint publications

Gwendolyn Swarbrick

3 joint publications

David M Lewinsohn

2 joint publications

Dylan Kain

2 joint publications

Wael Awad